Literature DB >> 26176282

Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.

Fernanda Torres1, Antonella Tosti2.   

Abstract

Diffuse hair loss in women causes a significant impact on quality of life, reduces self-esteem, and increases stress. One of the major challenges when evaluating patients with diffuse hair loss is to determine whether you are dealing with either female pattern alopecia, telogen effluvium, or both, as they can coexist. Establishing the correct diagnosis is mandatory for optimal patient care. This article will highlight how to distinguish between and properly manage these 2 conditions. ©2015 Frontline Medical Communications.

Entities:  

Keywords:  androgenetic alopecia; dermoscopy; female pattern hair loss; finasteride; hair loss; minoxidil; telogen effluvium; trichoscopy

Mesh:

Year:  2015        PMID: 26176282     DOI: 10.12788/j.sder.2015.0142

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  7 in total

Review 1.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

2.  Postpartum Telogen Effluvium Unmasking Traction Alopecia.

Authors:  Aman Samrao; Paradi Mirmirani
Journal:  Skin Appendage Disord       Date:  2022-01-28

Review 3.  Covid Induced Telogen Effluvium (CITE): An Insight.

Authors:  Arun C Inamadar
Journal:  Indian Dermatol Online J       Date:  2022-06-24

Review 4.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

5.  Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.

Authors:  Dursun Turkmen; Nihal Altunisik; Serpil Sener; Cemil Colak
Journal:  Dermatol Ther       Date:  2020-07-16       Impact factor: 3.858

6.  Management of telogen effluvium during the COVID-19 emergency: Psychological implications.

Authors:  Nicolò Rivetti; Stefania Barruscotti
Journal:  Dermatol Ther       Date:  2020-06-05       Impact factor: 3.858

7.  Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.

Authors:  Giulio Rizzetto; Federico Diotallevi; Anna Campanati; Giulia Radi; Tommaso Bianchelli; Elisa Molinelli; Sara Mazzanti; Annamaria Offidani
Journal:  Dermatol Ther       Date:  2020-11-23       Impact factor: 3.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.